vudalimab

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary MalignanciesNCT05032040XNCRPhase 2Active not recruiting2025-10-15Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.